logo
Why Franco-Nevada Stock Crawled Higher Today

Why Franco-Nevada Stock Crawled Higher Today

Yahoo3 days ago
Key Points
Two analysts raised their price targets following the release of second-quarter earnings.
Oddly, both lifted their fair value assessment by the same amount and landed at the same level.
10 stocks we like better than Franco-Nevada ›
Gold streaming and royalty company Franco-Nevada's (NYSE: FNV) stock had a bit of luster on the second trading day of the week. Its shares closed Tuesday up by almost 1.3% on a pair of analyst price-target hikes following the company's latest earnings release. That little pop was sufficient to edge past the S&P 500 index, which closed 1.1% higher.
Not one but two price-target bumps
Not one but two pundits following Franco-Nevada upped their fair value assessment on the stock; interestingly enough, each raised it by the same amount to the same level. TD Securities' Derick Ma and Scotiabank's Tanya Jakusconek now feel it's worth $184 per share (from their previous $182). However, the pair maintained their respective hold recommendations.
They did this despite the fact that Franco-Nevada delivered a second quarter featuring quite a convincing bottom-line beat.
Reporting that quarter's results Monday morning, Franco-Nevada said it achieved a new quarterly revenue figure of $369.4 million, which was an impressive 42% higher year over year. Generally accepted accounting principles (GAAP) net income more than tripled, landing at $247.1 million ($1.28 per share).
Despite the significant growth, Franco-Nevada's key fundamentals weren't too far off the consensus analyst estimates. These called for $375.9 million on the top line and $1.13 per share for GAAP net income.
Golden guidance
In its earnings release, management attributed the gains to higher prices for gold overall and the acquisition of a royalty in a Canadian mine
The company also proffered volume sales guidance for the entirety of 2025. It's anticipating its precious metal sales will range from 385,000 to 425,000 gold equivalent ounces (GEOs) for the year, with total GEOs landing at 465,000 to 525,000. The respective totals for the first six months of the year were 193,072 and 238,678. Franco-Nevada did not provide any financial guidance.
Should you buy stock in Franco-Nevada right now?
Before you buy stock in Franco-Nevada, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Franco-Nevada wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!*
Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of August 11, 2025
Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Why Franco-Nevada Stock Crawled Higher Today was originally published by The Motley Fool
擷取數據時發生錯誤
登入存取你的投資組合
擷取數據時發生錯誤
擷取數據時發生錯誤
擷取數據時發生錯誤
擷取數據時發生錯誤
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Merck & Co., Inc. (MRK) Impresses Jim Cramer With Its Toughness
Merck & Co., Inc. (MRK) Impresses Jim Cramer With Its Toughness

Yahoo

time6 minutes ago

  • Yahoo

Merck & Co., Inc. (MRK) Impresses Jim Cramer With Its Toughness

We recently published . Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim Cramer recently discussed. Merck & Co., Inc. (NYSE:MRK)'s shares have lost 16% year-to-date as investors continue to be disappointed by the dropping revenue of its GARDASIL HPV drug in China. They are also worried about the patent expiration of the firm's mega cancer drug KEYTRUDA and wondering whether Merck & Co., Inc. (NYSE:MRK) will be able to follow up with an equally successful successor. However, the shares did gain 3% this week after Pfizer announced that its bladder cancer drug PADCEV improves survival rates when paired with KEYTRUDA. Cramer was impressed as he commented: 'Look at Merck. I mean, Saint Merck. What a tough, what a tough.' Photo by National Cancer Institute on Unsplash Here are his earlier comments about Merck & Co., Inc. (NYSE:MRK): 'Well, this GARDASIL, when is it? The Chinese are not really helping them sell, because you would have thought the Chinese would. . .and then you've got the KEYTRUDA, you know the patent cliff coming up. . .it's amazing, but they are talking about their animal division. When you're talking about your animal division you don't have enough [inaudible] to talk.' While we acknowledge the potential of MRK as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio

U.S. Alcohol Consumption Hits 90-Year Low - Zero-Proof Spirits Like Arkay and Beyond Spirits Are Filling the Gap
U.S. Alcohol Consumption Hits 90-Year Low - Zero-Proof Spirits Like Arkay and Beyond Spirits Are Filling the Gap

Yahoo

time6 minutes ago

  • Yahoo

U.S. Alcohol Consumption Hits 90-Year Low - Zero-Proof Spirits Like Arkay and Beyond Spirits Are Filling the Gap

Health-conscious Americans are swapping liquor for plant-based, alcohol-free alternatives Miami, Florida--(Newsfile Corp. - August 15, 2025) - For the first time in nearly a century, alcohol consumption in the United States has fallen to historic lows. A surprising driver behind this shift? Younger, health-conscious consumers who are drinking less - or not at all - in favor of mindful, wellness-oriented lifestyles. This decline in traditional liquor sales is not a sign of the end for social drinking. Instead, it marks the beginning of a new era - one led by zero-proof spirits like Arkay Beverages and Beyond Spirits, the world's first plant-based, alcohol-free whisky. "We are witnessing the biggest drinking culture transformation in 90 years," said Reynald Vito Grattagliano, founder of Arkay Beverages and Beyond Spirits. "Consumers still want the taste, ritual, and social connection of spirits - but without the downsides of alcohol. Our zero-proof innovations deliver exactly that." According to industry analysts, several factors are fueling this trend: Gen Z & Millennials are choosing moderation and alcohol-free lifestyles at unprecedented rates. Health and wellness priorities are shifting spending toward low- and no-alcohol options. Innovation in taste and quality has made zero-proof spirits a viable alternative to traditional liquor. Arkay and Beyond Spirits stand at the forefront of this shift. Arkay offers a wide range of zero-proof alternatives to popular spirits - from whisky and rum to tequila and gin - all made without sugar, artificial sweeteners, or calories. Beyond Spirits takes plant-based innovation to the next level with its alcohol-free whisky crafted from 100% natural, sustainable ingredients. Why Zero-Proof Spirits Are the Future: Social without the hangover: Enjoy the experience of a night out without next-day regrets. Inclusive drinking culture: Alcohol-free options allow everyone to participate - from sober-curious to designated drivers. Better for body and mind: Supports mental clarity, fitness goals, and overall wellness. "This isn't a fad - it's a global movement," added Grattagliano. "Alcohol consumption may be at a 90-year low, but social connection and celebration are stronger than ever. Zero-proof spirits are the bridge between tradition and tomorrow." As Americans turn away from liquor, brands like Arkay and Beyond Spirits are proving that the future of drinking is not about alcohol - it's about choice, health, and innovation. About Arkay Beverages Founded in 2011, Arkay Beverages pioneered the zero-proof spirits category, offering alcohol-free alternatives to classic liquors. Each product is crafted to deliver the authentic taste of spirits without alcohol, sugar, or calories. About Beyond Spirits Beyond Spirits is the creator of the world's first plant-based, alcohol-free whisky. Combining innovation, sustainability, and craftsmanship, the brand delivers a premium drinking experience for health-conscious consumers worldwide. Press Contact: Person Name:Reynald Vito Grattagliano Media RelationsArkay Beverages & Beyond SpiritsEmail: press@ | To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

monday.com Ltd. (MNDY) Is Part Of The 'Enterprise Software Revulsion,' Says Jim Cramer
monday.com Ltd. (MNDY) Is Part Of The 'Enterprise Software Revulsion,' Says Jim Cramer

Yahoo

time6 minutes ago

  • Yahoo

monday.com Ltd. (MNDY) Is Part Of The 'Enterprise Software Revulsion,' Says Jim Cramer

We recently published . Ltd. (NASDAQ:MNDY) is one of the stocks Jim Cramer recently discussed. Ltd. (NASDAQ:MNDY) is an Israeli software company that develops and provides enterprise-focused products. Its shares have lost 22.8% year-to-date on the back of a stunning 29.8% drop in August, which underscores the brutal sentiment surrounding enterprise software in the age of AI. Ltd. (NASDAQ:MNDY) earnings were a negative catalyst, as even though the firm beat analyst and revenue estimates, the fact that its Q3 midpoint revenue guidance of $312 million missed analyst estimates of $313 million along with a conservative guidance hike and a weak Q2 beat were devastating for the shares. Here is what Cramer said about Ltd. (NASDAQ:MNDY): 'What I have here in my hand, Josh Baer . . .who upgrades, Morgan Stanley upgrades after, brutal, look at that, that's actually a decline. Now, why was Monday down? Monday is a company that does work processes. . . it's like a junior ServiceNow if you want to. Now it happened to have the misfortune of reporting on the same day that Ben Reitzes introduced the AI eats software, now actually a year and a half ago he actually coined that term so I don't know why people are thinking that he just did it. But this is all part of this, enterprise software revulsion. We don't want enterprise software, we want semiconductors. . .and I think that people should recognize that these companies are all being viewed as, let's say carrion, because what's happened is this that you can develop your own stuff that is better. Copyright: dolgachov / 123RF Stock Photo 'Look I just got to tell you I think that all these stocks are going to be shrinking in price-to-earnings multiples. You shouldn't be thinking about misses.' While we acknowledge the potential of MNDY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store